Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding
12
Zitationen
31
Autoren
2023
Jahr
Abstract
BACKGROUND: The National Hemophilia Foundation (NHF) conducted extensive, inclusive community consultations to guide prioritization of research in coming decades in alignment with its mission to find cures and address and prevent complications enabling people and families with blood disorders to thrive. RESEARCH DESIGN AND METHODS: With the American Thrombosis and Hemostasis Network, NHF recruited multidisciplinary expert working groups (WG) to distill the community-identified priorities into concrete research questions and score their feasibility, impact, and risk. WG6 was charged with identifying the infrastructure, workforce development, and funding and resources to facilitate the prioritized research. Community input on conclusions was gathered at the NHF State of the Science Research Summit. RESULTS: WG6 detailed a minimal research capacity infrastructure threshold, and opportunities to enable its attainment, for bleeding disorders centers to participate in prospective, multicenter national registries. They identified challenges and opportunities to recruit, retain, and train the diverse multidisciplinary care and research workforce required into the future. Innovative collaborative approaches to trial design, resource networking, and funding to surmount obstacles facing research in rare disorders were elucidated. CONCLUSIONS: The innovations in infrastructure, workforce development, and resources and funding proposed herein may contribute to facilitating a National Research Blueprint for Inherited Bleeding Disorders.
Ähnliche Arbeiten
Mutation in blood coagulation factor V associated with resistance to activated protein C
1994 · 3.834 Zit.
Hematological Problems in Pediatric Intensive Care
2013 · 3.515 Zit.
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
1993 · 1.984 Zit.
Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia
2007 · 1.924 Zit.
Guidelines for the management of hemophilia
2012 · 1.915 Zit.
Autoren
- Margaret V. Ragni
- Guy Young
- Glaivy Batsuli
- Emily Bisson
- Shannon L. Carpenter
- Stacy E. Croteau
- Adam Cuker
- Randall Curtis
- Michael Denne
- Bruce M. Ewenstein
- Amber Federizo
- Neil Frick
- Kerry Funkhouser
- Lindsey A. George
- W. Keith Hoots
- Shawn Jobe
- Emily Krava
- Christopher J. Langmead
- Roger Lewis
- José A. López
- Lynn Malec
- Ziva Mann
- Moses E. Miles
- Emma Neely
- Ellis J. Neufeld
- Glenn F. Pierce
- Steven W. Pipe
- Lisa R. Pitler
- Leslie Raffini
- Kathaleen M. Schnur
- Jordan A. Shavit
Institutionen
- National Hemophilia Foundation(US)
- University of Pittsburgh Medical Center(US)
- University of Southern California(US)
- Children's Hospital of Los Angeles(US)
- Emory University(US)
- Aflac (United States)(US)
- Children's Healthcare of Atlanta(US)
- Connecticut Children's Medical Center(US)
- Hartford Financial Services (United States)
- Children's Mercy Hospital(US)
- Boston Children's Hospital(US)
- Harvard University(US)
- University of Pennsylvania(US)
- Patient-Centered Outcomes Research Institute(US)
- Takeda (United States)(US)
- Children's Hospital of Philadelphia(US)
- National Institutes of Health(US)
- National Heart Lung and Blood Institute(US)
- Michigan State University(US)
- Carnegie Mellon University(US)
- Berry & Associates (United States)(US)
- University of Washington(US)
- Bloodworks Northwest(US)
- Versiti Blood Center of Wisconsin(US)
- American Society of Civil Engineers(US)
- American Thrombosis and Hemostasis Network(US)
- St. Jude Children's Research Hospital(US)
- Canadian Hemophilia Society(CA)
- University of Michigan(US)
- Michigan Medicine(US)
- Alliance for Clinical Trials in Oncology(US)
- Hemophilia Center of Western Pennsylvania(US)